Literature DB >> 23391146

GDNF gene delivery via a 2-(dimethylamino)ethyl methacrylate based cyclized knot polymer for neuronal cell applications.

B Newland1, M Abu-Rub, M Naughton, Y Zheng, A V Pinoncely, E Collin, E Dowd, W Wang, A Pandit.   

Abstract

Nonviral genetic therapeutic intervention strategies for neurological disorders hold great promise, but a lack of vector efficacy, coupled with vector toxicity, continue to hinder progress. Here we report the application of a newly developed class of polymer, distinctly different from conventional branched polymers, as a transfection agent for the delivery of glial cell line derived neurotrophic factor (GDNF) encoding gene. This new 2-(dimethylamino)ethyl methacrylate (DMAEMA) based cyclized knot polymer was studied for neuronal cell transfection applications, in comparison to branched polyethyleneimine (PEI). While showing a similar transfection profile over multiple cell types, the cyclized knot polymer showed far lower toxicity. In addition, transfection of Neu7 astrocytes with the GDNF encoding gene was able to cause neurite outgrowth when cocultured with dorsal root ganglia (DRGs). The cyclized knot polymer assessed here (PD-E 8%PEG), synthesized via a simple one-pot reaction, was shown to have great potential for neuronal gene therapy applications.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23391146      PMCID: PMC3630533          DOI: 10.1021/cn4000023

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  32 in total

1.  The reverse of polymer degradation: in situ crosslinked gel formation through disulfide cleavage.

Authors:  Aram O Saeed; Ben Newland; Abhay Pandit; Wenxin Wang
Journal:  Chem Commun (Camb)       Date:  2011-11-23       Impact factor: 6.222

2.  Rodent sensory neuron culture and analysis.

Authors:  Alison K Hall
Journal:  Curr Protoc Neurosci       Date:  2006-08

3.  A reliable method for detecting complexed DNA in vitro.

Authors:  C Holladay; M Keeney; B Newland; A Mathew; W Wang; A Pandit
Journal:  Nanoscale       Date:  2010-09-08       Impact factor: 7.790

4.  Non-viral gene delivery nanoparticles based on poly(β-amino esters) for treatment of glioblastoma.

Authors:  Stephany Y Tzeng; Hugo Guerrero-Cázares; Elliott E Martinez; Joel C Sunshine; Alfredo Quiñones-Hinojosa; Jordan J Green
Journal:  Biomaterials       Date:  2011-05-04       Impact factor: 12.479

5.  A highly effective gene delivery vector--hyperbranched poly(2-(dimethylamino)ethyl methacrylate) from in situ deactivation enhanced ATRP.

Authors:  Ben Newland; Hongyun Tai; Yu Zheng; Diego Velasco; Andrea Di Luca; Steven M Howdle; Cameron Alexander; Wenxin Wang; Abhay Pandit
Journal:  Chem Commun (Camb)       Date:  2010-06-01       Impact factor: 6.222

6.  Long-term transgene expression in the central nervous system using DNA nanoparticles.

Authors:  David M Yurek; Anita M Fletcher; George M Smith; Kim B Seroogy; Assem G Ziady; Joseph Molter; Tomasz H Kowalczyk; Linas Padegimas; Mark J Cooper
Journal:  Mol Ther       Date:  2009-02-17       Impact factor: 11.454

7.  Low polydispersity (N-ethyl pyrrolidine methacrylamide-co-1-vinylimidazole) linear oligomers for gene therapy applications.

Authors:  D Velasco; G Réthoré; B Newland; J Parra; C Elvira; A Pandit; L Rojo; J San Román
Journal:  Eur J Pharm Biopharm       Date:  2012-08-23       Impact factor: 5.571

8.  Intravenous glial-derived neurotrophic factor gene therapy of experimental Parkinson's disease with Trojan horse liposomes and a tyrosine hydroxylase promoter.

Authors:  Chun-Fang Xia; Ruben J Boado; Yun Zhang; Chun Chu; William M Pardridge
Journal:  J Gene Med       Date:  2008-03       Impact factor: 4.565

9.  Neuroprotection in a 6-hydroxydopamine-lesioned Parkinson model using lactoferrin-modified nanoparticles.

Authors:  Rongqin Huang; Liang Han; Jianhua Li; Feiliang Ren; Weilun Ke; Chen Jiang; Yuanying Pei
Journal:  J Gene Med       Date:  2009-09       Impact factor: 4.565

10.  GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo.

Authors:  C M Kearns; D M Gash
Journal:  Brain Res       Date:  1995-02-20       Impact factor: 3.252

View more
  7 in total

Review 1.  Destination Brain: the Past, Present, and Future of Therapeutic Gene Delivery.

Authors:  Chaitanya R Joshi; Vinod Labhasetwar; Anuja Ghorpade
Journal:  J Neuroimmune Pharmacol       Date:  2017-02-03       Impact factor: 4.147

2.  Encapsulation of primary dopaminergic neurons in a GDNF-loaded collagen hydrogel increases their survival, re-innervation and function after intra-striatal transplantation.

Authors:  Niamh Moriarty; Abhay Pandit; Eilís Dowd
Journal:  Sci Rep       Date:  2017-11-22       Impact factor: 4.379

3.  Brain repair for Parkinson's disease: is the answer in the matrix?

Authors:  Niamh Moriarty; Eilís Dowd
Journal:  Neural Regen Res       Date:  2018-07       Impact factor: 5.135

4.  Highly branched  poly(β-amino ester) delivery of minicircle DNA for transfection of neurodegenerative disease related cells.

Authors:  Shuai Liu; Yongsheng Gao; Dezhong Zhou; Ming Zeng; Fatma Alshehri; Ben Newland; Jing Lyu; Jonathan O'Keeffe-Ahern; Udo Greiser; Tianying Guo; Fengzhi Zhang; Wenxin Wang
Journal:  Nat Commun       Date:  2019-07-24       Impact factor: 14.919

Review 5.  Cyclodextrins in non-viral gene delivery.

Authors:  Wing-Fu Lai
Journal:  Biomaterials       Date:  2013-10-05       Impact factor: 12.479

6.  Isolation and characterisation of a recombinant antibody fragment that binds NCAM1-expressing intervertebral disc cells.

Authors:  Claire Cunningham; Akshay Srivastava; Estelle Collin; Sibylle Grad; Mauro Alini; Abhay Pandit; J Gerard Wall
Journal:  PLoS One       Date:  2013-12-13       Impact factor: 3.240

7.  Reaching for the Stars in the Brain: Polymer-Mediated Gene Delivery to Human Astrocytes.

Authors:  Chaitanya R Joshi; Vijay Raghavan; Sivakumar Vijayaraghavalu; Yue Gao; Manju Saraswathy; Vinod Labhasetwar; Anuja Ghorpade
Journal:  Mol Ther Nucleic Acids       Date:  2018-06-28       Impact factor: 8.886

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.